Women's Health

UroMems champions positive results for stress urinary incontinence implant

UroMems has reported more positive results from a trial evaluating its UroActive device for the treatment of stress urinary incontinence.…

2024 kicks off with a surge in clinical trials tackling women’s infertility

Currently, the health of women and girls appears to be a pertinent issue that the pharma industry is addressing, as…

Femasys opens another site in trial for permanent birth control device

Femasys’ pivotal FINALE trial for its permanent birth control device is well under way, and the women’s health company has…

BioNTech and DualityBio begin trial of breast cancer therapy

BioNTech and DualityBio have begun a Phase III trial of BNT323/DB-1303, an antibody-drug conjugate (ADC) candidate for the treatment of…

Comanche raises $75m to develop preeclampsia therapy

US-based Comanche Biopharma has raised $75m in an oversubscribed Series B financing round to develop its small interfering RNA (siRNA)…

TiumBio raises $12m to advance clinical pipeline development

South Korean TiumBio has raised KRW20bn ($12m) through stock financing to fund the development of its clinical programmes. The capital…

GSK’s Jemperli with chemo meets primary goal in endometrial cancer trial

GSK has reported that part two of the Phase III RUBY/ENGOT-EN6/GOG3031/NSGO clinical trial of Jemperli (dostarlimab) plus chemotherapy in adults…

Seagen seeks new approval for Tukysa in HER2+ breast cancer

On 6 December 2023 at the San Antonio Breast Cancer Symposium, the results of the Phase III HER2CLIMB-02 trial were…

Daré Bioscience launches Phase III hormone-free contraceptive trial

US biopharma firm Daré Bioscience has started a Phase III trial investigating the effectiveness and safety of Ovaprene, a hormone-free…

Lack of women’s data is causing femtech start ups to lose out on VC funding

The length of time needed for femtech startups to conduct studies to support their technologies is deterring venture capital (VC)…

close

Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Vist our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close